Sharekhan

Shalby Ltd

Thu 13/03/2025,15:59:7 | NSE : SHALBY

₹ 205.984.65 (2.31%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 200.10

Previous Close

₹ 201.33

Volume

347047

Mkt Cap ( Rs. Cr)

₹2224.79

High

₹ 209.69

Low

₹ 200.10

52 Week High

₹ 325.00

52 Week Low

₹ 180.35

Book Value Per Share

₹ 93.25

Dividend Yield

0.58

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Shalby Ltd

Your Vote -

Buy

65.52%

Hold

10.34%

Sell

24.14%

65.52%

29 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

205.98

10

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

10

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Shalby Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Shalby - Announcement under Regulation 30 (LODR)-Credit Rating

    4 Mar 2025, 6:25PM Credit Rating
  • Shalby - Credit Rating

    4 Mar 2025, 6:24PM Shalby Limited has informed the Exchange about Credit Rating
  • Shalby - Receipt Of Hand Transplant Approval

    11 Feb 2025, 7:56PM Shalby Hospital, Ahmedabad has received approval for registration for Hand Transplant under Transplantation of Human Organs Act, 1994
  • Shalby - Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals

    11 Feb 2025, 7:56PM Shalby Limited has informed the Exchange about regulatory approvals for Hand Transplant
  • Shalby - Copy of Newspaper Publication

    11 Feb 2025, 3:11PM Shalby Limited has informed the Exchange about Copy of Newspaper Publication about dispatch of Postal Ballot Notice and Remote e-voting information
  • Shalby - Analysts/Institutional Investor Meet/Con. Call Updates

    11 Feb 2025, 12:50PM Shalby Limited has informed the Exchange about Transcript
  • Shalby - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    11 Feb 2025, 12:48PM Transcript of Earning Conference Call held on 5th February 2025 at 2:30 for discussion on Financial and Operational performance on standalone and cons
  • Shalby - Notice Of Shareholders Meetings-XBRL

    10 Feb 2025, 5:54PM SHALBY LIMITED has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot
  • Shalby - Shareholders meeting

    10 Feb 2025, 11:21AM Shalby Limited has informed the Exchange regarding Notice of Postal Ballot
  • Shalby - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    10 Feb 2025, 11:20AM Notice of Postal Ballot
  • Shalby - Updates

    7 Feb 2025, 6:58PM Shalby Limited has informed the Exchange regarding 'Grant of ESOP'.
  • Shalby - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    7 Feb 2025, 6:58PM Grant of ESOP under Shalby Limited Stock Option Scheme-2021
  • Shalby - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Req

    6 Feb 2025, 7:33PM Disclosure under Regulation 30 SEBI (LODR) - Action taken or order passed
  • Shalby - Action(s) taken or orders passed

    6 Feb 2025, 7:33PM Shalby Limited has informed the Exchange about Action(s) taken or orders passed
  • Shalby - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    5 Feb 2025, 5:52PM Link of recording for Earnings Conference Call held on 5th February 2025 at 2:30 p.m.
  • Shalby - Analysts/Institutional Investor Meet/Con. Call Updates

    5 Feb 2025, 5:52PM Shalby Limited has informed the Exchange about Link of Recording
  • Shalby - Investor Presentation

    4 Feb 2025, 6:50PM Shalby Limited has informed the Exchange about Investor Presentation
  • Shalby - Announcement under Regulation 30 (LODR)-Investor Presentation

    4 Feb 2025, 6:50PM Investor Presentation to be discussed at Earning Call scheduled on February 5, 2025
  • Shalby - Copy of Newspaper Publication

    4 Feb 2025, 2:35PM Shalby Limited has informed the Exchange about Copy of Newspaper Publication
  • Shalby - Press Release

    4 Feb 2025, 11:21AM Shalby Limited has informed the Exchange regarding a press release dated February 04, 2025, titled ""Financial performance by Shalby Group in Q3 FY25
  • Shalby - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    4 Feb 2025, 11:21AM Press Release titled financial performance by Shalby Group in Q3FY23 with Revenue up by 27.4% YoY
  • Shalby - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    4 Feb 2025, 10:06AM SHALBY LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
  • Shalby - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    3 Feb 2025, 8:19PM Grant of ESOP under Shalby Limited Employee Stock Option Scheme-2021
  • Shalby - Updates

    3 Feb 2025, 8:17PM Shalby Limited has informed the Exchange regarding 'Grant of ESOP under Shalby Limited Employee Stock Option Scheme-2021'.
  • Shalby - Integrated Filing- Financial

    3 Feb 2025, 8:07PM Integrated Filing (Financials) for quarter ended December 31, 2024
  • Shalby - Integrated Filing (Financial)

    3 Feb 2025, 8:07PM Integrated Filing (Financial) for quarter ended December 31, 2024
  • Shalby Q3 net profit down 15.61% at Rs 20.86 cr

    3 Feb 2025, 8:00PM The company reported standalone net profit of Rs 20.86 crore for the quarter ended December 31, 2024 as compared to Rs 24.72 crore in the same period
  • Shalby - Appointment

    3 Feb 2025, 7:54PM Shalby Limited has informed the Exchange regarding Appointment of Dr. Vikram Indrajit Shah as Chairman & Managing Director of the company w.e.f. Marc
  • Shalby - Announcement under Regulation 30 (LODR)-Change in Management

    3 Feb 2025, 7:54PM Re-appointment of Dr. Vikram Indrajit Shah, as Chairman and Managing Director
  • Shalby - Outcome of Board Meeting

    3 Feb 2025, 7:41PM Shalby Limited has informed the Exchange regarding Board meeting held on February 03, 2025.
  • Shalby - Board Meeting Outcome for Outcome Of Board Meeting Held On 3Rd February 2025

    3 Feb 2025, 7:41PM Outcome of Board Meeting held on 3rd February 2025
  • Shalby - Unaudited Standalone And Consolidated Financial Results For Quarter Ended December 31, 2024

    3 Feb 2025, 7:36PM Unaudited Standalone and Consolidated Financial results for quarter ended December 31, 2024
  • Shalby - Financial Result Updates

    3 Feb 2025, 7:36PM Shalby Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
  • Shalby - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    28 Jan 2025, 3:07PM Schedule of Earnings Call on February 5, 2025 at 2:30 p.m. IST to discuss Q3 FY 2024-25 earnings
  • Shalby - Analysts/Institutional Investor Meet/Con. Call Updates

    28 Jan 2025, 3:07PM Shalby Limited has informed the Exchange about Schedule of meet
  • Shalby - Board Meeting Intimation

    28 Jan 2025, 1:26PM SHALBY LIMITED has informed the Exchange about Board Meeting to be held on 03-Feb-2025 to consider and approve the Quarterly Unaudited Financial resul
  • Shalby - Update on board meeting

    28 Jan 2025, 4:00PM The Board Meeting to be held on 03/02/2025 has been revised to 03/02/2025 The Board Meeting to be held on 03/02/2025 has been revised to 03/02/2025
  • Shalby - Board Meeting Intimation for Considering And Approving The Unaudited Standalone And Consolidated Financial Results F

    28 Jan 2025, 1:24PM Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2025 ,inter alia, to consider and approve u
  • Shalby - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    16 Jan 2025, 5:52PM Schedule of Analyst / Investor meet
  • Shalby - Analysts/Institutional Investor Meet/Con. Call Updates

    16 Jan 2025, 5:52PM Shalby Limited has informed the Exchange about Schedule of meet
  • Shalby - Updates

    16 Jan 2025, 2:05PM Shalby Limited has informed the Exchange regarding 'Inauguration of Shalby Tissue & Bone Bank at Krishna Shalby Hospital, Ahmedabad'.
  • Shalby - Inauguration Of Shalby Tissue & Bone Bank At Krishna Shalby Hospital, Ahmedabad

    16 Jan 2025, 2:05PM Inauguration of Shalby Tissue & Bone Bank at Krishna Shalby Hospital, Ahmedabad
  • Shalby - Shalby Advanced Technologies (SAT) Inc., USA Received US FDA Approval For Its Product

    15 Jan 2025, 6:03PM Shalby Advanced Technologies (SAT) Inc. , USA received US FDA approval for its product
  • Shalby - Updates

    15 Jan 2025, 6:00PM Shalby Limited has informed the Exchange regarding 'Shalby Advanced Technologies (SAT) Inc., USA received US FDA approval for its Product'.
  • Shalby has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024

    6 Jan 2025, 12:10PM As of December 2024, 74.27% is owned by Indian Promoters, 25.04% by Public and 0.69% by Non Promoters-Non Public. <p align=justify> Top five Promoters
  • Shalby - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    3 Jan 2025, 4:51PM Certificate under Reg. 74(5) under SEBI (Depositories and Participants) Regulations, 2018 for quarter ended December 31, 2024
  • Shalby - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    3 Jan 2025, 4:51PM Shalby Limited has informed the Exchange about Certificate under Reg. 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for quarter ende
  • Shalby - Trading Window-XBRL

    27 Dec 2024, 12:43PM SHALBY LIMITED has informed the Exchange about Closure of Trading Window
  • Shalby - Trading Window

    27 Dec 2024, 12:38PM Shalby Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
  • Shalby

    19 Jan 2024 , 10:28AM Shalby Limited, India’s leading multi‐specialty hospital, has announced a strategic investment in PK Healthcare Pvt Ltd with an acquisition of 87.26% equity stake for a consideration of Rs 102 Cr. The Hospital is located at prime location of Golf Course Road, Gurugram. With a land parcel of 1.27 acres which has been taken on a long‐term lease. The current capacity of 130 beds facility can be expanded to the level of 180 beds with additional capex. With this acquisition, Sanar International hospitals will be able take advantage of Shalby’s global presence and leadership in Orthopaedics. Shalby will be able to serve its patients from international market and northern part of India, which will help to accelerate the revenue of the group. (Positive)
  • Shalby

    23 Nov 2023 , 11:12AM The company has executed the Amendment Agreement to the Operation and Management Agreement with The Santacruz Residents Association and Smt. Bhikhubai Chandulal Jalundwala General Hospital (BCJ) for execution of the project (construction of New hospital building) at Santacruz, Mumbai. The Company will construct 175 bedded new hospital at Santacruz, Mumbai, equipped with state‐of‐ the‐art equipment and technology, thereby leveraging our quality multi‐specialty services to many people of the city (Positive)
  • Shalby

    29 Mar 2023 , 12:19PM Shalby Ltd. has invested Rs. 50 Cr through non-cumulative, non-convertible but redeemable preference shares in its subsidiary, Mars Medical Devices Ltd., taking the subsidiary’s total paid up capital go up to Rs. 150 Cr from Rs. 100 Cr before.
  • Shalby provides $9.45 m letter of credit for US arm

    14 Dec 2022 , 2:17PM Shalby issue SBLC amounting to USD 9.45 million for Shalby Advanced Technologies, Inc. USA

Key fundamentals

Evaluate the intrinsic value of Shalby Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 1176.2 995.819 948.029 885.149 862.467
Liabilities 1176.2 995.819 948.029 885.149 862.467
Equity 107.413 107.31 108.01 108.01 108.01
Gross Profit 177.569 142.157 130.014 86.126 81.506
Net Profit 103.845 80.808 69.806 42.881 27.972
Cash From Operating Activities 139.772 164.528 100.98 82.446 57.087
NPM(%) 12.51 11.41 10.78 10.24 5.78
Revenue 829.682 708.017 647.16 418.669 483.886
Expenses 652.113 565.86 517.146 332.543 402.38
ROE(%) 10.31 8.02 6.93 4.25 2.77

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
19 Sep 2024 1.2 12 0.58 267.1
08 Aug 2023 1.2 12 0.58 137.6
19 Sep 2022 1 10 0.58 104
17 Sep 2021 1 10 0.58 138.45
04 Sep 2020 0.5 5 0.58 70
16 Aug 2019 0.5 5 0.58 130.55

Peers

Other companies within the same industry or sector that are comparable to Shalby Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 808.20 -1.14 11.41 117.65 1321.50 1.42
Lotus Eye Hospital and Institute Ltd 57.06 -0.77 237.75 428.72 14.01 0.88
Vaishali Pharma Ltd 12.12 -5.90 606.00 220.98 2.31 0.00
Astec Lifesciences Ltd 653.90 -5.55 0.00 404.24 -239.30 0.00

Company Info

The Company was originally incorporated as Shalby Hospital Private Limited on August 30, 2004 at Ahmedabad, Gujarat, India, as a private limited company under the Companies Act, 1956. Subsequently, the Company was converted to a public limited company and a fresh certificate of incorporation consequent upon change of name on conversion to a public limited company was issued by the RoC on May 15, 2006 in the name of Shalby Hospital Public Limited. The name of the Company was subsequently changed to Shalby Hospitals Limited, and a fresh certificate of incorporation consequent upon change of name was issued by the RoC on July 26, 2006. Thereafter, the name of the Company was changed to Shalby Limited, and a fresh certificate of incorporation consequent upon change of name was issued by the RoC on February 13, 2008. The change to the name of our Company from Shalby Hospital Private Limited to Shalby Hospital Public Limited was undertaken upon conversion of the Company from a private limited company to a public limited company. Subsequent changes to the name of the Company to Shalby Hospitals Limited and Shalby Limited were undertaken to explore other activities as mentioned in the main objects of the Memorandum of Association. MAJOR EVENTS AND MILESTONES OF OUR COMPANY 2007 -Established and commenced operations of our first multi-specialty hospital, SG Shalby, at Sarkhej Gandhinagar Highway in Ahmedabad 2013 -Krishna Shalby commences operations -Shalby Vapi commences operations 2015 -Shalby Jabalpur commences operations 2016 -Shalby Indore commences operations -Executed a memorandum of understanding with ZH Private Limited to manage and operate Zynova Shalby -Executed an O&M agreement with Kamesh Hospital to commence operations of Shalby Mohali 2017 -Entered into an agreement with Bait Al Batterjee Medical Company LLC, Dubai, to provide outpatient orthopaedics and spine surgeries AWARDS AND ACCREDITATIONS 2017 -Best CSR Initiative in Healthcare Award -The Best Hospital for Medical Tourism of Gujarat Award 2016 -The Best Medical Tourism Centre of Gujarat Award -Gujarat Ratna Award 2015 -Emerging Tertiary Care Hospital of the Year Award 2014 -Best Multi-specialty Hospital - Metro -Company of the Year Award (In recognition of valuable contribution towards healthcare) -Hercules Award 2013 -Healthcare Service Provider Company of the Year Award (In the category for companies generating annual revenue below ?5,000 million) 2012 -Best Medium Enterprise Award 2011 -FICCI Healthcare Operational Excellence Award 2010 -Rajiv Gandhi National Quality Award. 2018-"Shalby Bagged Medical Value Travel Specialist Hospital Award 2018 for Orthopaedics.2019-Shalby Hospitals conferred with the best hospital for Medical Tourism in Gujarat Award.-Shalby Hospitals bestowed with best IT enabled Hospital Award 2019.2020 -Shalby Bestowed With The Best Hospital For Patient Care Award.-Inauguration of First Orthopedic & Joint Replacement Franchise at Udaipur. 2021 -Shalby Hospitals Conferred with "Best Medical Tourism Centre of Gujarat Award2022 -Shalby Hospitals awarded as the BEST ORTHOPEDIC HOSPITAL in India by The Economic Times.

The Company was originally incorporated as Shalby Hospital Private Limited on August 30, 2004 at Ahmedabad, Gujarat, India, as a private limited company under the Companies Act, 1956. Subsequently, the Company was converted to a public limited company and a fresh certificate of incorporation consequent upon change of name on conversion to a public limited company was issued by the RoC on May 15, 2006 in the name of Shalby Hospital Public Limited. The name of the Company was subsequently changed to Shalby Hospitals Limited, and a fresh certificate of incorporation consequent upon change of name was issued by the RoC on July 26, 2006. Thereafter, the name of the Company was changed to Shalby Limited, and a fresh certificate of incorporation consequent upon change of name was issued by the RoC on February 13, 2008. The change to the name of our Company from Shalby Hospital Private Limited to Shalby Hospital Public Limited was undertaken upon conversion of the Company from a private limited company to a public limited company. Subsequent changes to the name of the Company to Shalby Hospitals Limited and Shalby Limited were undertaken to explore other activities as mentioned in the main objects of the Memorandum of Association. MAJOR EVENTS AND MILESTONES OF OUR COMPANY 2007 -Established and commenced operations of our first multi-specialty hospital, SG Shalby, at Sarkhej Gandhinagar Highway in Ahmedabad 2013 -Krishna Shalby commences operations -Shalby Vapi commences operations 2015 -Shalby Jabalpur commences operations 2016 -Shalby Indore commences operations -Executed a memorandum of understanding with ZH Private Limited to manage and operate Zynova Shalby -Executed an O&M agreement with Kamesh Hospital to commence operations of Shalby Mohali 2017 -Entered into an agreement with Bait Al Batterjee Medical Company LLC, Dubai, to provide outpatient orthopaedics and spine surgeries AWARDS AND ACCREDITATIONS 2017 -Best CSR Initiative in Healthcare Award -The Best Hospital for Medical Tourism of Gujarat Award 2016 -The Best Medical Tourism Centre of Gujarat Award -Gujarat Ratna Award 2015 -Emerging Tertiary Care Hospital of the Year Award 2014 -Best Multi-specialty Hospital - Metro -Company of the Year Award (In recognition of valuable contribution towards healthcare) -Hercules Award 2013 -Healthcare Service Provider Company of the Year Award (In the category for companies generating annual revenue below ?5,000 million) 2012 -Best Medium Enterprise Award 2011 -FICCI Healthcare Operational Excellence Award 2010 -Rajiv Gandhi National Quality Award. 2018-"Shalby Bagged Medical Value Travel Specialist Hospital Award 2018 for Orthopaedics.2019-Shalby Hospitals conferred with the best hospital for Medical Tourism in Gujarat Award.-Shalby Hospitals bestowed with best IT enabled Hospital Award 2019.2020 -Shalby Bestowed With The Best Hospital For Patient Care Award.-Inauguration of First Orthopedic & Joint Replacement Franchise at Udaipur. 2021 -Shalby Hospitals Conferred with "Best Medical Tourism Centre of Gujarat Award2022 -Shalby Hospitals awarded as the BEST ORTHOPEDIC HOSPITAL in India by The Economic Times.

Read More

Parent Organisation

Shalby Ltd.

Founded

30/08/2004

Managing Director

Dr.Vikram Shah

NSE Symbol

SHALBYEQ

FAQ

The current price of Shalby Ltd is ₹ 205.98.

The 52-week high for Shalby Ltd is ₹ 209.69 and the 52-week low is ₹ 200.10.

The market capitalization of Shalby Ltd is currently ₹ 2224.79. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Shalby Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Shalby Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Shalby Ltd shares.

The CEO of Shalby Ltd is Dr.Vikram Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT